Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:24 pm Sale |
2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Cormorant Asset Management LP | 3,195,544 7.960% |
-75,000 (-2.29%) |
Filing History |
| 2021-02-16 3:16 pm Unchanged |
2020-12-31 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 2,292,060 7.120% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:15 pm Sale |
2021-02-16 | 13G | Stoke Therapeutics, Inc. STOK |
Cormorant Asset Management LP | 1,437,807 3.970% |
-350,856 (-19.62%) |
Filing History |
| 2021-02-16 3:14 pm Sale |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 1,904,424 7.920% |
-214,709 (-10.13%) |
Filing History |
| 2021-02-16 3:13 pm Sale |
2020-12-31 | 13G | PRINCIPIA BIOPHARMA INC PRNB |
Cormorant Asset Management LP | 0 0.000% |
-1,990,922 (Position Closed) |
Filing History |
| 2021-02-16 3:12 pm Sale |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
Cormorant Asset Management LP | 2,392,297 4.960% |
-1,004,353 (-29.57%) |
Filing History |
| 2021-02-16 3:11 pm Sale |
2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Cormorant Asset Management LP | 0 0.000% |
-2,300,000 (Position Closed) |
Filing History |
| 2021-02-16 3:10 pm Sale |
2020-12-31 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,464,547 6.570% |
-49,998 (-1.99%) |
Filing History |
| 2021-02-16 3:09 pm Sale |
2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
Cormorant Asset Management LP | 0 0.000% |
-1,144,537 (Position Closed) |
Filing History |
| 2021-02-16 3:08 pm Purchase |
2020-12-31 | 13G | Omeros Corporation OMER |
Cormorant Asset Management LP | 5,000,000 8.100% |
1,900,000 (+61.29%) |
Filing History |
| 2021-02-16 3:07 pm Sale |
2020-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
Cormorant Asset Management LP | 0 0.000% |
-1,350,000 (Position Closed) |
Filing History |
| 2021-02-16 3:06 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 4,460,000 9.970% |
1,080,630 (+31.98%) |
Filing History |
| 2021-02-16 3:04 pm Purchase |
2021-12-31 | 13G | Otonomy, Inc. OTIC |
Cormorant Asset Management LP | 2,600,000 5.390% |
100,000 (+4.00%) |
Filing |
| 2021-02-16 3:03 pm Sale |
2020-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
Cormorant Asset Management LP | 2,490,065 5.790% |
-3 (-0.00%) |
Filing History |
| 2021-02-16 3:02 pm Sale |
2020-12-31 | 13G | Agenus Inc. AGEN |
Cormorant Asset Management LP | 356,650 3.700% |
-229,275 (-39.13%) |
Filing History |
| 2021-02-16 3:01 pm Sale |
2020-12-31 | 13G | ChemoCentryx, Inc. CCXI |
Cormorant Asset Management LP | 1,200,000 1.700% |
-2,186,208 (-64.56%) |
Filing History |
| 2021-02-16 3:00 pm Sale |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 2,495,066 3.800% |
-750,111 (-23.11%) |
Filing History |
| 2021-01-19 4:18 pm Purchase |
2021-01-07 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Cormorant Asset Management LP | 459,144 9.990% |
459,144 (New Position) |
Filing History |
| 2021-01-04 4:01 pm Purchase |
2020-12-22 | 13G | NOVUS THERAPEUTICS INC NVUS |
Cormorant Asset Management LP | 1,415,500 9.890% |
1,415,500 (New Position) |
Filing History |
| 2020-12-28 4:01 pm Purchase |
2020-12-18 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 2,292,060 7.120% |
2,292,060 (New Position) |
Filing History |